An Arkansas diagnostic testing company has received authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 antibody test.
- NOWDiagnostics, a Springdale-based company, announced earlier this week that it had been granted Emergency Use Authorization (EUA) for its ADEXUSDx antibody test. This EUA is for use in “moderate-complex settings” and at the point-of-care.
- Quote: "The ADEXUSDx COVID-19 Test uses the same platform as our other FDA-cleared and/or CE marked, next-generation tests which are affordable, portable, and deliver laboratory-quality results in minutes without any additional supplies."
Discover more about the breakthrough test HERE.